{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:03:08Z","timestamp":1794276188801,"version":"4.9.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Breast cancer is the most common cancer in women. However, in the management of breast cancer, paraneoplastic neurological syndromes represent a diagnostic and therapeutic challenge. The diagnosis of paraneoplastic neurological syndromes is difficult due to the heterogeneity of symptoms, the timing of presentation, and the absence of antibodies, and it generally occurs before the diagnosis of breast cancer in 80% of patients who develop paraneoplastic neurological syndromes. We describe a 72-year-old woman with subacute ophthalmoplegia-ataxia syndrome who was subsequently diagnosed as having breast cancer and anti-Ri antibodies.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 72-year-old post-menopausal Caucasian woman, with a positive medical history for diabetes mellitus and hypertension, presented with a 3-month onset of blurred vision, diplopia, and progressive gait disturbance. Serological tests were positive for well-characterized onconeural antibodies (anti-Ri). A whole-body computed tomography scan revealed a nodular opacity under her left nipple and axillary adenopathy. A biopsy of her left breast was performed, and histological examination showed ductal carcinoma. She underwent a superoexternal quadrantectomy with left axillary dissection. The final diagnosis showed infiltrating ductal carcinoma of the breast (T1c N1 M0, stage IIA) associated with paraneoplastic ophthalmoplegia-ataxia syndrome. At a 6-month follow-up, she showed no clinical or instrumental evidence of neoplastic recurrence with partial clinical improvement of neurological symptoms, such as ataxia and diplopia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The diagnosis of paraneoplastic neurological syndromes is often late, as in this patient, but treatment at an early stage may provide a good prognosis. Furthermore, this is one of several cases of an anti-Ri paraneoplastic neurological syndrome not associated with myoclonus, which reinforces the belief that opsoclonus myoclonus syndrome is not pathognomonic of the associated anti-Ri paraneoplastic neurological syndromes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13256-020-02410-z","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T23:05:30Z","timestamp":1591916730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-3250","authenticated-orcid":false,"given":"Giuseppe","family":"Sena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Vescio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"de Franciscis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariuccia","family":"Renne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"issue":"1","key":"2410_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334..","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2410_CR2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Lippi G. Current Cancer Epidemiology. J Epidemiol Glob Health. 2019;9(4):217\u201322.","journal-title":"J Epidemiol Glob Health"},{"key":"2410_CR3","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349:1543\u201354.","journal-title":"N Engl J Med"},{"key":"2410_CR4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","volume":"16","author":"F Graus","year":"2019","unstructured":"Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2019;16:535\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"2410_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000055405","volume":"61","author":"M Piccart","year":"2001","unstructured":"Piccart M, Lohrisch C, Di Leo A, Larsimont D. The predictive value of HER2 in breast cancer. Oncology. 2001;61:73\u201382.","journal-title":"Oncology"},{"key":"2410_CR6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/neuonc\/nos006","volume":"14","author":"I Rojas-Marcos","year":"2012","unstructured":"Rojas-Marcos I, Picard G, Chinch\u00f3n D, Gelpi E, Psimaras D, Giometto B, et al. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo\u2013associated paraneoplastic cerebellar degeneration. Neuro-Oncology. 2012;14:506\u201310.","journal-title":"Neuro-Oncology"},{"issue":"1","key":"2410_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/NRL.0b013e3181870aa2","volume":"15","author":"TB Toothaker","year":"2009","unstructured":"Toothaker TB, Rubin M. Paraneoplastic neurological syndromes: a review. Neurologist. 2009;15(1):21\u201333.","journal-title":"Neurologist"},{"issue":"3","key":"2410_CR8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10549-017-4566-0","volume":"167","author":"BL Murphy","year":"2018","unstructured":"Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ. Breast cancer-related paraneoplastic neurologic disease. Breast Cancer Res Treat. 2018;167(3):771\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"2410_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","volume":"56","author":"SJ Pittock","year":"2004","unstructured":"Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004;56:715\u20139.","journal-title":"Ann Neurol"},{"issue":"2","key":"2410_CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1750-3639.1999.tb00226.x","volume":"9","author":"J Dalmau","year":"1999","unstructured":"Dalmau J, Gultekin HS, Posner JB. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol. 1999;9(2):275\u201384.","journal-title":"Brain Pathol"},{"key":"2410_CR11","first-page":"7(3):e699","volume":"13","author":"C Simard","year":"2020","unstructured":"Simard C, Vogrig A, Joubert B, Mu\u00f1iz-Castrillo S, Picard G, Rogemond V. Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol Neuroimmunol Neuroinflamm. 2020;13:7(3):e699.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2410_CR12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.12659\/AJCR.889560","volume":"14","author":"S Said","year":"2013","unstructured":"Said S, Cooper CJ, Reyna E, Alkhateeb H, Diaz J, Nahleh Z. Paraneoplastic limbic encephalitis, an uncommon presentation of a common cancer: case report and discussion. Am J Case Rep. 2013;14:391\u20134.","journal-title":"Am J Case Rep"},{"issue":"8","key":"2410_CR13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"2410_CR14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","volume":"123","author":"SH Gultekin","year":"2000","unstructured":"Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(7):1481\u201394.","journal-title":"Brain."},{"issue":"1","key":"2410_CR15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/bcr3620","volume":"16","author":"C Criscitiello","year":"2014","unstructured":"Criscitiello C, Esposito A, Gelao L, Fumagalli L, Locatelli M, Minchella I, et al. Immune approaches to the treatment of breast cancer, around the corner? Breast Cancer Res. 2014;16(1):204.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"2410_CR16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/pr700818f","volume":"7","author":"H Lu","year":"2008","unstructured":"Lu H, Goodell V, Disis ML. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. J Proteome Res. 2008;7(4):1388\u201394.","journal-title":"J Proteome Res"},{"issue":"10","key":"2410_CR17","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1172\/JCI14451","volume":"108","author":"EM Tan","year":"2001","unstructured":"Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest. 2001;108(10):1411\u20135.","journal-title":"J Clin Invest"},{"issue":"2","key":"2410_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2004.12.017","volume":"230","author":"MF Fernandez","year":"2005","unstructured":"Fernandez MF. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. Cancer Lett. 2005;230(2):187\u201398.","journal-title":"Cancer Lett"},{"issue":"23","key":"2410_CR19","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1111\/j.1742-4658.2009.07396.x","volume":"276","author":"HT Tan","year":"2009","unstructured":"Tan HT, et al. Serum autoantibodies as biomarkers for early cancer detection. FEBS J. 2009;276(23):6880\u2013904.","journal-title":"FEBS J"},{"issue":"3","key":"2410_CR20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00262-010-0956-4","volume":"60","author":"C Domschke","year":"2011","unstructured":"Domschke C, Schuetz F, Ge Y, Rom J, Zorn M, Sinn HP, et al. Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha\/IL-12 in breast cancer patients. Cancer Immunol Immunother. 2011;60(3):401\u201311.","journal-title":"Cancer Immunol Immunother"},{"issue":"16","key":"2410_CR21","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1158\/0008-5472.CAN-05-4201","volume":"66","author":"N Sommerfeldt","year":"2006","unstructured":"Sommerfeldt N, Sch\u00fctz F, Sohn C, F\u00f6rster J, Schirrmacher V, Beckhove P. The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients. Cancer Res. 2006;66(16):8258\u201365.","journal-title":"Cancer Res"},{"key":"2410_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40164-016-0058-x","volume":"5","author":"I Fanous","year":"2016","unstructured":"Fanous I, Dillon P. Paraneoplastic neurological complications of breast cancer. Exp Hematol Oncol. 2016;5:29.","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"2410_CR23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.10518","volume":"53","author":"SJ Pittock","year":"2003","unstructured":"Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol. 2003;53(5):580\u20137.","journal-title":"Ann Neurol"},{"issue":"6","key":"2410_CR24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","volume":"126","author":"S Shams'ili","year":"2003","unstructured":"Shams'ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003;126(6):1409\u201318.","journal-title":"Brain"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02410-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-020-02410-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02410-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T23:35:00Z","timestamp":1623454500000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02410-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02410-z","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Ethics Committee of \u201cMagna Graecia\u201d University. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}